Private Equity

Over 3.5 million Africans suffer from psoriasis with little support. A historic forum in Nairobi aims to shatter the silence and forge a new path for care.

As Guild Garage adds two Washington firms, its own recent sale to a private equity giant reveals a massive consolidation play in the home services industry.

Beijing hails Xizang's economic boom, but critics point to a deep erosion of culture and rights. What is the true story of development on the roof of the world?

Exscape Group adds another Columbus landscaper to its portfolio, highlighting a private equity-fueled consolidation trend in the Midwest's green industry.

Activist investor Irenic Capital is demanding a new committee to oversee Teleflex's strategic review, escalating a public battle over the company's future.

A new partnership tokenizes a fund holding SpaceX and OpenAI shares, making elite private market investments accessible onchain for the first time globally.

A new energy firm will drill for oil in Greenland under a legacy permit, clashing with the nation's 2021 ban and setting up a high-stakes environmental fight.

California's The Grotto Menswear expands to Phoenix, trading transactional retail for a personalized, community-driven suiting experience.

Now the deadliest cancer for Americans under 50, advocates descend on Washington to demand urgent research funding for a growing national health crisis.

As Adventure Life expands globally, its success reveals a growing trend: travelers are trading DIY booking for the high-touch service of expert advisors.

Westcliff University opens a new Dallas campus, betting its career-focused model can supply the talent needed for the region's explosive economic growth.

A Denver clinic now offers Therapeutic Plasma Exchange for anti-aging. But does the science back up the high-cost promise of turning back the clock?

Amid soaring healthcare costs, The Difference Card appoints sales directors for the Southeast and West, signaling an aggressive push to expand its reach.

A landmark partnership is scaling a 'one-drug, many-diseases' therapy, revealing how logistics, not just labs, are key to the future of medicine.

Independent firm FPA is nominated for a top Morningstar award alongside PIMCO and Vanguard, highlighting its rare focus on investor returns over asset size.

Despite citizenship law debates, investor demand for Portugal's Golden Visa remains strong, signaling a strategic shift towards long-term residency.

Allspring's closed-end funds offer tempting yields, but tiny shifts in their monthly payouts reveal a complex story of risk, return, and capital erosion.

RenX Enterprises touts massive growth after a reverse split, but a closer look reveals dilution risks, a heavy debt load, and a paid promotional campaign.

A landmark partnership aims to tap Australia's vast Beetaloo gas reserves for domestic use and LNG export, igniting both economic hopes and fierce opposition.

Aperture Investors’ European Innovation Fund sweeps the LSEG Lipper awards by exploiting market inefficiencies with a unique, disciplined long/short strategy.